CD4 and neoplasm: Despite the late onset of the immunotherapy also after vaccination alone improved infiltration of CD8+ T cells (fold change 1.4) and CD4+ T cells (fold change 0.6) could be observed suggesting beneficial effects of the immunotherapy even with the high tumor burden.